THE SCIENCE

What is suPAR?

A revolutionary biomarker that measures chronic inflammation and predicts patient outcomes

BRIEFLY EXPLAINED

suPAR

suPAR (soluble urokinase Plasminogen Activator Receptor) is a biomarker of chronic inflammation. The kind that builds quietly over years, long before a patient feels anything or standard tests flag a concern.

Higher suPAR levels are linked to greater risk of cancer, diabetes, cardiovascular disease, and organ failure. Lower levels point to good underlying health and stronger long-term resilience. It’s a simple number that carries a lot of clinical weight.

BRIEFLY EXPLAINED

Chronic inflammation

Inflammation is meant to protect and repair the body. But when the immune system stays activated for too long, even without injury or infection, that response can begin to wear the body down over time.

suPAR measures this underlying inflammatory burden, offering insight into the biological strain associated with aging, disease risk, and reduced resilience.

BRIEFLY EXPLAINED

Biological age

Two people can be the same age on paper, yet their bodies may be aging very differently. That difference is known as biological age.

suPAR helps measure the underlying inflammatory stress associated with aging, lifestyle, and long-term health. Higher levels may indicate a faster pace of aging, while lower levels are linked to stronger resilience over time.